PR93189

WILMINGTON, Del., On, Nov. 19, 2021 /PRNewswire=KYODO JBN/--

- Stopping the unlicensed manufacture, marketing, and sales of HFO-1234yf

refrigerants protects innovation and customers

The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with

leading market positions in Titanium Technologies, Thermal & Specialized

Solutions, Advanced Performance Materials and Chemical Solutions, announced  

that it files a second patent infringement lawsuit in Japan against AGC, Inc.

This action reaffirms Chemours' commitment to vigorously defend its

intellectual property and investment in Opteon(TM) low global warming potential

(GWP) refrigerants and builds on its on-going efforts to stop the unlicensed

manufacture, marketing, and sales of Opteon(TM) HFO-1234yf (R-1234yf)

refrigerant by all legal means wherever that activity occurs around the world.

The second lawsuit was filed on November 12, 2021 with the Tokyo District Court

Civil Divisio (case number 2021(Wa)29388). It alleges infringement of Chemours'

patents covering HFO-1234yf product compositions. This is a great example of

Chemours' using its international patent estate in order to protect its

investment in the development and commercialization of HFO-1234yf and to ensure

that customers obtain authentic refrigerant.

Chemours offers a full portfolio of low GWP HFO solutions under the Opteon(TM)

brand that delivers the optimal balance of performance, safety, sustainability

and total cost of ownership to meet the long-term needs of the commercial

refrigeration, air conditioning, heat pump, and chiller markets. They have been

developed to help meet increasingly stringent global regulations while

maintaining or improving performance compared to the products they replace, as

well as encouraging more sustainable refrigerant choices and equipment designs

to reduce the carbon footprint of the HVACR industry.

For more information on Opteon(TM) refrigerants, please visit opteon.com

About The Chemours Company

The Chemours Company (Chemours or the Company) (NYSE: CC) is a global leader in

Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance

Materials, and Chemical Solutions providing its customers with solutions in a

wide range of industries with market-defining products, application expertise

and chemistry-based innovations. We deliver customized solutions with a wide

range of industrial and specialty chemicals products for markets, including

coatings, plastics, refrigeration, and air conditioning, transportation,

semiconductor and consumer electronics, general industrial, mining and oil and

gas.  Our flagship products include prominent brands such as Ti-Pure(TM),

Opteon(TM), Freon(TM), Nafion(TM), Krytox(TM), Teflon(TM), and Viton(TM). In

2019, Chemours was named to Newsweek's list of America's Most Responsible

Companies. The company has approximately 6,500 employees and 30 manufacturing

sites serving approximately 3,300 customers in approximately 120 countries.

Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE

under the symbol CC.

For more information, we invite you to visit chemours.com or follow us on

Twitter @Chemours or LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of

Section 27A of the Securities Act of 1933 and Section 21E of the Securities

Exchange Act of 1934, which involve risks and uncertainties. Forward-looking

statements provide current expectations of future events based on certain

assumptions and include any statement that does not directly relate to a

historical or current fact. The words "believe," "expect," "will,"

"anticipate," "plan," "estimate," "target," "project" and similar expressions,

among others, generally identify "forward-looking statements," which speak only

as of the date such statements were made. These forward-looking statements may

address, among other things, the outcome or resolution of any pending or future

environmental liabilities, the commencement, outcome or resolution of any

regulatory inquiry, investigation or proceeding, the initiation, outcome or

settlement of any litigation, changes in environmental regulations in the U.S.

or other jurisdictions that affect demand for or adoption of our products,

anticipated future operating and financial performance for our segments

individually and our company as a whole, business plans, prospects, targets,

goals and commitments, capital investments and projects and target capital

expenditures, plans for dividends or share repurchases, sufficiency or

longevity of intellectual property protection, cost reductions or savings

targets, plans to increase profitability and growth, our ability to make

acquisitions, integrate acquired businesses or assets into our operations, and

achieve anticipated synergies or cost savings, all of which are subject to

substantial risks and uncertainties that could cause actual results to differ

materially from those expressed or implied by such statements. Forward-looking

statements are based on certain assumptions and expectations of future events

that may not be accurate or realized. These statements are not guarantees of

future performance. Forward-looking statements also involve risks and

uncertainties that are beyond Chemours' control. In addition, the current

COVID-19 pandemic has significantly impacted the national and global economy

and commodity and financial markets, which has had and we expect will continue

to have a negative impact on our financial results. The full extent and impact

of the pandemic is unknown and to date has included extreme volatility in

financial and commodity markets, a significant slowdown in economic activity,

and increased predictions of a global recession. The public and private sector

response has led to significant restrictions on travel, temporary business

closures, quarantines, stock market volatility, and a general reduction in

consumer and commercial activity globally. Matters outside our control have

affected our business and operations and may or may continue to limit travel of

employees to our business units domestically and internationally, adversely

affect the health and welfare of our personnel, significantly reduce the demand

for our products, hinder our ability to provide goods and services to

customers, cause disruptions in our supply chains, adversely affect our

business partners or cause other unpredictable events. Additionally, there may

be other risks and uncertainties that Chemours is unable to identify at this

time or that Chemours does not currently expect to have a material impact on

its business. Factors that could cause or contribute to these differences

include the risks, uncertainties and other factors discussed in our filings

with the U.S. Securities and Exchange Commission, including in our Quarterly

Report on Form 10-Q for the quarter ended September 30, 2021 and in our Annual

Report on Form 10-K for the year ended December 31, 2020. Chemours assumes no

obligation to revise or update any forward-looking statement for any reason,

except as required by law.

SOURCE:  Chemours